Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Skysis Named A "Fastest-Growing Company" By Inc 5000 For The Third Year In A Row

Posted on: 23 Aug 17
Skysis Named A "Fastest-Growing Company" By Inc 5000 For The Third Year In A Row Skysis Reports Three-Year Annual Revenue Growth That Exceeds 30%

PR Newswire

SCOTTSDALE, Ariz., Aug. 23, 2017

SCOTTSDALE, Ariz., Aug. 23, 2017 /PRNewswire-iReach/ -- Skysis, a commercial services provider to biopharmaceutical companies, is pleased to announce that the company has been ranked #2654 on Inc. magazine's 36th annual Inc. 5000, an exclusive ranking of the nation's fastest-growing private companies. The list represents a unique look at the most successful companies within the American economy's most dynamic segment— its independent small and midsized businesses.

"Being named to the Inc. 5000 list for the third year in a row is exciting and gratifying," said Dan Twibell, Managing Director at Skysis. "The entire Skysis team works so hard on behalf of our clients helping them achieve and exceed their goals. Our continued growth is evidence of the long–standing client partnerships we value so highly."

Skysis Managing Director Dawn Rich added, "Over the last year, our market access practice has seen significant growth, and we have enhanced our new product planning and commercialization services with advanced technology. We are very excited about the future."

The 2017 Inc. 5000, unveiled online at is the most competitive crop in the list's history. The average company on the list achieved a mind-boggling three-year average growth of 481%. The Inc. 5000's aggregate revenue is $206 billion, and the companies on the list collectively generated 619,500 jobs over the past three years. Complete results of the Inc. 5000 can be found at

About Skysis

Skysis is a team of experienced commercial professionals that provides in-depth strategic insights and commercial execution to biopharmaceutical companies. Through proven processes and an extensive network of subject matter experts, Skysis delivers specialized capabilities in the areas of New Product Planning, Market Access, Strategic Advisory Services, Market Research and Brand Management. Skysis has more than 85 professionals in the US with a footprint and capabilities that extend across Europe and Asia/Pac. The company's mission is to partner with its clients to help them achieve a higher level of success. Visit us at

About Inc. Media

Founded in 1979 and acquired in 2005 by Mansueto Ventures, Inc. is the only major brand dedicated exclusively to owners and managers of growing private companies, with the aim to deliver real solutions for today's innovative company builders. Winner of the National Magazine Award for General Excellence in both 2014 and 2012. Total monthly audience reach for the brand has grown significantly from 2,000,000 in 2010 to over 18,000,000 today.  For more information, visit

The Inc. 5000 is a list of the fastest-growing private companies in the nation. Started in 1982, this prestigious list of the nation's most successful private companies has become the hallmark of entrepreneurial success. The Inc. 5000 Conference & Awards Ceremony is an annual event that celebrates their remarkable achievements. The event also offers informative workshops, celebrated keynote speakers, and evening functions. For more information on Inc. and the Inc. 5000 Conference, visit


Judy Lawson


Media Contact: Judy Lawson, Skysis, 614-668-7026,

News distributed by PR Newswire iReach:



PR Newswire

Last updated on: 23/08/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.